Early Magnetic Resonance Detection of Natalizumab-Related Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Sclerosis
Figure 2
T1 post-Gd images (Philips Achieva 3T, TR/TE = 500 msec./14 msec, 15 cc Gadobenate Dimeglumine, Multihance) in December 2011 (a) and May 2012 (b) of the white matter lesion underneath the frontal lobe of the left hemisphere (arrows) without detectable contrast enhancement in a 44-year-old man with a 12-year history of MS affected by natalizumab-related PML.
